358 related articles for article (PubMed ID: 21493890)
1. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
[TBL] [Abstract][Full Text] [Related]
2. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
Zhang P; Hu X; Xu X; Chen Y; Bache RJ
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):890-7. PubMed ID: 21212404
[TBL] [Abstract][Full Text] [Related]
3. DDAH says NO to ADMA.
Cooke JP; Ghebremariam YT
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1462-4. PubMed ID: 21677286
[No Abstract] [Full Text] [Related]
4. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
Lange C; Mowat F; Sayed H; Mehad M; Duluc L; Piper S; Luhmann U; Nandi M; Kelly P; Smith A; Ali R; Leiper J; Bainbridge J
Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226
[TBL] [Abstract][Full Text] [Related]
5. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.
Liu X; Xu X; Shang R; Chen Y
Nitric Oxide; 2018 Aug; 78():113-120. PubMed ID: 29928990
[TBL] [Abstract][Full Text] [Related]
7. Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor-promoted differentiation of PC12 cells in a nitric oxide-dependent but asymmetric dimethylargenine-independent manner.
Wang S; Hu CP; Yuan Q; Zhang WF; Zhou Z; Nie SD; Jiang JL; Li YJ
J Neurosci Res; 2012 Jun; 90(6):1209-17. PubMed ID: 22488726
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.
Hu X; Xu X; Zhu G; Atzler D; Kimoto M; Chen J; Schwedhelm E; Lüneburg N; Böger RH; Zhang P; Chen Y
Circulation; 2009 Dec; 120(22):2222-9. PubMed ID: 19917889
[TBL] [Abstract][Full Text] [Related]
9. Disruption of methylarginine metabolism impairs vascular homeostasis.
Leiper J; Nandi M; Torondel B; Murray-Rust J; Malaki M; O'Hara B; Rossiter S; Anthony S; Madhani M; Selwood D; Smith C; Wojciak-Stothard B; Rudiger A; Stidwill R; McDonald NQ; Vallance P
Nat Med; 2007 Feb; 13(2):198-203. PubMed ID: 17273169
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
Xu X; Zhang P; Kwak D; Fassett J; Yue W; Atzler D; Hu X; Liu X; Wang H; Lu Z; Guo H; Schwedhelm E; Böger RH; Chen P; Chen Y
Basic Res Cardiol; 2017 Aug; 112(5):55. PubMed ID: 28819685
[TBL] [Abstract][Full Text] [Related]
12. Effect of asymmetric dimethylarginine (ADMA) on heart failure development.
Liu X; Hou L; Xu D; Chen A; Yang L; Zhuang Y; Xu Y; Fassett JT; Chen Y
Nitric Oxide; 2016 Apr; 54():73-81. PubMed ID: 26923818
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
Torondel B; Nandi M; Kelly P; Wojciak-Stothard B; Fleming I; Leiper J
Vasc Med; 2010 Jun; 15(3):205-13. PubMed ID: 20219849
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
Dayal S; Rodionov RN; Arning E; Bottiglieri T; Kimoto M; Murry DJ; Cooke JP; Faraci FM; Lentz SR
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H816-25. PubMed ID: 18567702
[TBL] [Abstract][Full Text] [Related]
16. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.
Dowsett L; Piper S; Slaviero A; Dufton N; Wang Z; Boruc O; Delahaye M; Colman L; Kalk E; Tomlinson J; Birdsey G; Randi AM; Leiper J
Circulation; 2015 Jun; 131(25):2217-25. PubMed ID: 25910799
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.
Ivashchenko CY; Bradley BT; Ao Z; Leiper J; Vallance P; Johns DG
Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H251-8. PubMed ID: 19915177
[TBL] [Abstract][Full Text] [Related]
20. Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.
Tomlinson JA; Caplin B; Boruc O; Bruce-Cobbold C; Cutillas P; Dormann D; Faull P; Grossman RC; Khadayate S; Mas VR; Nitsch DD; Wang Z; Norman JT; Wilcox CS; Wheeler DC; Leiper J
J Am Soc Nephrol; 2015 Dec; 26(12):3045-59. PubMed ID: 25855779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
